Abstract Library

#4287 Challenges in access to peptide receptor radionuclide therapy (PRRT) in developing countries – Insights from patient advocacy perspective

Introduction: As patient advocates and advocacy groups emerge as pivotal players in promoting access to healthcare, we explore their role in promoting radionuclide therapy in NETs.

Conference:

Presenting Author: Dureja S

Authors: Dureja S,

Keywords: Neuroendocrine tumour, Patient Advocacy, PRRT, Theranostics, Developing countries,

#4084 Proteomic profiling reveals C1QA and COMP as promising plasma biomarkers for early detection of pancreatic neuroendocrine tumors

Introduction: PanNETs (pancreatic neuroendocrine tumors) have distinctive clinical features and may vary in aggressiveness. Current diagnostic methods, including biochemical tests and imaging techniques, lack the required sensitivity and specificity, with invasive and expensive procedures. The urgent need for specific, cost-effective biomarkers for early PanNET screening and diagnosis is emphasized, especially in developing countries.

Conference:

Presenting Author: Gorai P

Authors: Gorai P, Bharti P, Surabhi A, Kumar S, Rajacharya G,

Keywords: Pancreatic neuroendocrine tumor, Proteomics, Biomarker, Plasma,

#2696 Difficulties in Providing Palliative Care in Rural India (West Bengal) – Experience of an NGO

Introduction: As in any developing countries state of West Bengal in India has a huge burden of cancer patients in advanced stage coming from rural area where awareness regarding the usefulness of palliative care in rather poor.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Mandal N,

Keywords: Cancer, palliative care, rural India, psychological,

#23 Developing a customized database for NET in a developing country

Introduction: The establishment of a neuroendocrine registry is extremely hard in developing countries. Many patients miss follow-up after surgical procedures and many die in different hospitals with a distinct national security health system number. As in any developing country, Brazil has a large movement of people to urban areas, making the tracking of former addresses impossible for patients who were treated some years prior. Therefore, it is more feasible to evaluate a demographic distribution of neuroendocrine tumors by topography or histological subtype, but the analysis of clinical events, such as progression-free survival, disease-free survival, time to progression or overall survival, is compromised.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author: Garicochea B

Authors: Bós A, Shavinsky C, Pereira de Carvalho G, Barcellos de Almeida P, Scandura K,

Keywords: NET, software, developing country, registry,